Feb 19, 2026 08:01AM
Jan 29, 2026 08:05AM
Dec 29, 2025 08:00AM
Dec 12, 2025 04:46PM
Dec 11, 2025 01:43PM
Nov 14, 2025 05:44PM
Oct 16, 2025 08:32AM Enveric Biosciences receives 23rd U.S. patent for neuroplastogen compounds
Oct 15, 2025 08:01AM
Oct 14, 2025 09:02AM
Oct 2, 2025 08:45AM
Sep 29, 2025 04:33PM
Sep 18, 2025 04:30PM
Sep 17, 2025 09:24AM
Sep 16, 2025 08:45AM Enveric Biosciences plans early 2026 IND filing for EB-003 after FDA feedback
Jul 23, 2025 08:03AM
Jul 15, 2025 09:04AM
Jun 24, 2025 09:03AM
Jun 10, 2025 09:03AM
Jun 3, 2025 09:01AM
May 28, 2025 09:03AM
May 20, 2025 08:06AM Enveric Biosciences Inc. (ENVB) Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
May 14, 2025 06:37PM
Apr 10, 2025 06:26AM
Mar 6, 2025 10:00AM
Feb 27, 2025 09:30AM
Feb 25, 2025 01:30PM
Jan 30, 2025 04:03PM
Dec 2, 2024 08:03AM Enveric Biosciences Inc. (ENVB) Announces New U.S. Patents Supporting EVM301 and EVM201
Nov 15, 2024 06:17AM
Nov 12, 2024 09:02AM
Nov 4, 2024 09:00AM
Aug 13, 2024 08:01AM
Aug 13, 2024 07:00AM
Jul 25, 2024 08:03AM
Jul 15, 2024 09:03AM Enveric Biosciences (ENVB) and Aries Science Enter Licensing Agreement
Jul 10, 2024 08:00AM
Jul 8, 2024 05:13PM
Jun 25, 2024 08:03AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All